Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

COVID-19 Telehealth Coding

Theresa Thompson, CPC one of the featured practice management speakers for the Annual Meeting, has…

read more

Health Policy Updates tied to COVID-19

HILL UPDATES Senate Republicans released an updated version of the CARES Act on Sunday, March…

read more

USP Compounding Standards Update

A letter from the USP Healthcare Quality & Safety from March 12th, 2020 Dear Colleague,…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/15/20: Fellow Exam Application Deadline
Learn more

06/01/20: Research Grant Cycle
Learn more

06/26/20: Membership Application Deadline to be eligible for AAOA Member rate for the 2020 Basic Course Learn more

07/15/20: Call for Scientific Papers
Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

12/01/20: Research Grant Cycle
Learn more

EDUCATION

New Virtual Course!

Register now as we build out Part 2 Core Allergy & Part 3 Core Rhinology.   Both promise to deliver clinical content you need.  Core Allergy will offer what you need to help refresh or add allergy to your practice — everything from the clinical science to the basics of allergy from a better understanding of testing techniques, vial prep, and dose calculations to other practical implications.  Core Rhinology encompassed the highly sought after rhinology content from our former IAR program.  Part 1 will launch soon with on demand content to help you balance all your time demands.  Part 2 & 3 will feature live-stream content to give you opportunities to interact with the faculty.  Post live session, this content will also be available on demand. Stay tuned for more details as we finish our program build. Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

NEW VIRTUAL COURSE! Core Allergy and Rhinology Concepts: Age of Pandemics and Beyond
Learn How to Reboot Your Practice and Freshen Up on Core Allergy and Rhinology Components
Learn More and Register

2020 Basic Course in Allergy & Immunology
July 9-11 | Orlando, FL
COVID-19 has made it impossible to convene our 2020 Basic Course. We hope you will consider another AAOA CME opportunity

2020 AAOA Annual Meeting
October 23-25| Scottsdale, AZ
Learn More and Register

2020 Advanced Course in Allergy & Immunology
December 9-12 | Vail, CO
Learn More and Register

AAOA Clinical Insights
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 Basic Course in Allergy & Immunology
July 15-17 | Seattle, WA

News and Updates

First Drug for Treatment of Peanut Allergy for Children is Approved by FDA

“Peanut allergy affects approximately 1 million children in the U.S. and only 1 out of…

read more

Revised CPT Code for 2020

The following revisions and additions to Current Procedural Terminology (CPT ® American Medical Association) codes related…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Menu
AAOA Advocacy

Interim Package and Resuming Non-COVID Care

Sharing the latest on the interim package and the news from CMS about resuming non-COVID care.

HILL UPDATES

  • Interim Package:
    • Despite signs of progress, an agreement on this package was not reached today. The Senate scheduled a pro forma session for Tuesday afternoon to try to pass the interim package assuming a deal is reached and the House could vote as soon as Wednesday.
    • We can expect to see approximately $300 billion for the Paycheck Protection Program (with a portion of these funds set aside for small lenders), $75 billion for providers, $65 billion for the SBA Economic Injury Disaster Loan program and $25 billion for testing.
  • COVID-4: The reports of its timing keep changing, but the latest we’ve heard from Hill staff is mid-May for the package.
  • House Energy and Commerce Chairman Pallone sent a letter to the Task Force on National Testing Strategy asking inquiring what actions the Administration taking to expand testing and prepare for eventually easing its guidelines on social distancing. Chairman Pallone requested answers to these questions by April 24, 2020.
  • Senator Patty Murray released a White Paper outlining the Democrats’ proposal to increase national COVID-19 testing.

ADMINISTRATION UPDATES

  • CMS released guidelines for some health care facilities to resume non-emergent non-COVID care in areas where there is a low incidence of COVID-19.
  • CMS has updated their FAQ on Medicare Fee-for-Service (FFS) billing here.
  • CMS Administrator Seema Verma announced that CMS expects to release data on COVID-19 outcomes specific to race and ethnicity in early May once the agency has claims from April with COVID-19 codes.
  • In an effort to ramp up testing, President Trump is invoking the Defense Production Act to produce 20 million more COVID-19 testing swabs.
  • Despite announcing that COVID-19 treatment will be covered for the uninsured, the administration still has not announced a plan to operationalize this.  POLITICO reported that a portion of the Public Health Emergency Fund could be used for this purpose.